Richie Kahn, MPH

A health policy professional by training, clinical researcher by trade and patient advocate by necessity, Richie Kahn has spent the last 15 years working across the industry to reduce the time it takes to bring promising new treatments to the patients that need them most. As Co-Founder & COO of Canary Advisors, Richie partners with biopharma, nonprofit, and regulatory stakeholders to better align clinical development programs with patient wants and needs.